# Gosta Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gosta-labs

- Industry: Software
- Headquarters: Espoo, Finland
- Website: www.gostalabs.com
- Total disclosed funding: $8.7M
- Latest round: Seed (Nov 27, 2025)
- Investors on record: 4

## About

Based in Finland, Gosta Labs Oy delivers AI-driven solutions tailored for the healthcare sector, focusing on automating clinical workflows to improve patient care and operational efficiency.Gosta Labs Oy, founded in 2023 in Espoo, Finland, specializes in healthcare AI technology. The company has received EUR 7.5 mn in Seed funding led by Voima Ventures, which will support its growth initiatives. The sole funding round to date resulted in a total of EUR 7.5 mn raised. Gosta Labs has executed one deal as of November 27, 2025. The company was founded by individuals with a background in healthcare technology, although further details about their previous ventures are not disclosed.Gosta Labs specializes in advanced AI solutions designed specifically for the healthcare sector, with its flagship product being the Gosta AI Operating System. This system integrates features akin to a personal assistant with the intelligence of an AI operating system, automating administrative tasks such as note generation and patient data structuring, ultimately enabling healthcare professionals to focus more on patient interactions. The Gosta AI Operating System has been implemented across tens of thousands of clinical appointments, demonstrating its utility in real-world clinical settings. The primary end users of Gosta Labs' products include healthcare professionals and providers in public and private healthcare settings across various regions, including Europe and potentially extending to global markets. By combining medical expertise with cutting-edge AI technology built on secure infrastructure, Gosta Labs aims to enhance patient care and streamline clinical workflows.Gosta Labs generates revenue through partnerships and subscriptions, providing its AI solutions to healthcare providers and institutions. The company's primary offering, the Gosta AI Operating System, is available on a subscription basis, allowing clients to integrate the AI systems into their existing workflows seamlessly. Transaction structures typically involve direct partnerships with healthcare organizations, where Gosta Labs collaborates closely to implement its solutions in clinical settings. Revenue streams are bolstered by the adoption of Gosta Aide, a personal assistant tool that enhances productivity for healthcare professionals. Specific pricing details for these services have not been disclosed, but the focus remains on delivering high-quality AI solutions that enhance clinical practice and patient care.In November 2025, Gosta Labs Oy raised EUR 7.5 mn in Seed funding to expand deployment of its oncology-focused AI operating system worldwide. The funding will be utilized to strengthen its medical-grade AI infrastructure and accelerate the rollout of the system with cancer care teams, enabling them to automate clinical documentation and structure patient data in real time. The company aims to enter new geographic markets with a focus on enhancing its presence in Europe and potentially other global regions.

## Funding rounds

- Seed, Nov 27, 2025, $8.7M — Reaktor Ventures, Voima Ventures, COR Group, the Aho family

## Investors

- Reaktor Ventures — Seed
- Voima Ventures (https://capitalatlas.ai/funds/voima-ventures) — Seed
- COR Group (https://capitalatlas.ai/funds/cor-group) — Seed
- the Aho family — Seed